Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Syros Garners $30,000,000 Series A Financing 04/12/13 Boston
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
How to Make the Payers Pay: Join the Xconomy Event April 9 03/26/13 Seattle
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
Biotech for the Belt-Tightening Era: Last Chance For Early-Bird Tix 03/12/13 Seattle
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
The Road to Predictable Innovation: Genomics in Drug R&D 12/10/12 Boston
Amgen Acquires DeCode Genetics, the Once-Fallen Star, for $415M 12/10/12 National
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
908 Devices Garners $8,100,000 Series A Funding Round 09/06/12 Boston
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
San Diego’s Sapphire Energy Producing Green Crude From NM Algae Farm 08/27/12 San Diego
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Impinj Backs Away from IPO, Raises $21.6M from Private Sources 07/26/12 Seattle
Siluria Attracts Paul Allen, Gets $30M to Turn Natural Gas Into Chemicals, Fuels 07/26/12 San Francisco
Siluria Technologies Lands $30,000,000 Series C Funding Round 07/26/12 San Francisco
Bluebird Bio Snags $60M From Existing VCs and Newcomers Like Shire 07/25/12 Boston
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Accelerator Looks to Expand, With an Eye on the Big Apple 06/01/12 Seattle
SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy 05/03/12 San Diego
Biotech IPOs Start to Show Some Modest Signs of Life 04/30/12 National
Page 2 of 13 « previous page · next page »